Polymorphisms in AURKA and AURKB are associated with the survival of triple-negative breast cancer patients treated with taxane-based adjuvant chemotherapy

Polymorphisms in AURKA and AURKB are associated with the survival of triple-negative breast cancer patients treated with taxane-based adjuvant chemotherapy

Yuqian Liao,1,* Yulu Liao,2,* Jun Li,2 Junyu Li,2 Ying Fan,3 Binghe Xu3 1Department of Medical Oncology, Jiangxi Cancer Hospital, Nanchang, Jiangxi Province, People’s Republic of China; 2Department of Radiation Oncology, Jiangxi Cancer Hospital, Nanchang, Jiangxi Province, People&rsquo...

Full description

Bibliographic Details
Main Authors: Liao Y, Li J, Fan Y, Xu B
Format: Article
Language:English
Published: Dove Medical Press 2018-09-01
Series:Cancer Management and Research
Subjects:
Aurora kinase
TNBC
polymorphism
survival
Online Access:https://www.dovepress.com/polymorphisms-in-aurka-and-aurkb-are-associated-with-the-survival-of-t-peer-reviewed-article-CMAR

Internet

https://www.dovepress.com/polymorphisms-in-aurka-and-aurkb-are-associated-with-the-survival-of-t-peer-reviewed-article-CMAR

Similar Items